Stocktoria

DiaMedica Therapeutics Inc. DMAC

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2008-01-04

DiaMedica Therapeutics Inc. statistics & valuation

Market cap$352.9M
P / B6.3×
Return on equity-58.4%
Return on capital-61.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201720182019202020212022202320242025
Operating margin (%)
-1352.20% 201720182019202020212022202320242025
Return on equity (%)
-533.20% -33.70% -139.80% -47.30% -30.90% -43.00% -38.00% -60.00% -58.40% 201720182019202020212022202320242025
Shares outstanding
6.4M 12.0M 12.0M 18.7M 26.4M 26.4M 38.0M 42.8M 53.7M 201720182019202020212022202320242025
Net debt ($)
201720182019202020212022202320242025
Share buybacks ($)
201720182019202020212022202320242025
Return on assets (%)
-236.40% -31.30% -117.60% -43.80% -29.80% -39.80% -35.80% -52.70% -53.40% 201720182019202020212022202320242025
Free cash flow margin (%)
-1149.20% 201720182019202020212022202320242025
Debt / equity (×)
201720182019202020212022202320242025
EPS ($)
201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin———————-1352.2%—
Net margin———————-1146.8%—
FCF margin———————-1149.2%—
Return on assets-53.4%-52.7%-35.8%-39.8%-29.8%-43.8%-117.6%-31.3%-236.4%
Return on equity-58.4%-60.0%-38.0%-43.0%-30.9%-47.3%-139.8%-33.7%-533.2%
Current ratio11.818.2819.2715.6129.8213.776.7013.871.49

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.